Search research articles
Contact Us
Filters
Showing results (931-940 of 968) with videos related to
Page
of 97
Sort By:
Blood Advances
|
April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL Amyloidosis
Maximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Blood Cancer Journal
|
June 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma
Binoy Yohannan, Benjamin W Langworthy, Lindsey E Turner, et al.
Mayo Clinic Proceedings
|
April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013
Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Nature Genetics
|
August 20, 2025
Temporal genomic dynamics shape clinical trajectory in multiple myeloma
Francesco Maura, Marcella Kaddoura, Alexandra M Poos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Antonio Palumbo, Hervé Avet-Loiseau, Stefania Oliva, et al.
Blood
|
July 8, 2017
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma
Jonas Paludo, Joseph R Mikhael, Betsy R LaPlant, et al.
The New England Journal of Medicine
|
December 9, 2014
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma
A Keith Stewart, S Vincent Rajkumar, Meletios A Dimopoulos, et al.
American Journal of Hematology
|
January 11, 2021
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort
Maria Eleni Drosou, Lisa E Vaughan, Eli Muchtar, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2024
Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma
Francesco Maura, Marcella Kaddoura, Alexandra M Poos, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 10, 2001
The discovery of sulfonylated dipeptides as potent VLA-4 antagonists
W K Hagmann, P L Durette, T Lanza, et al.
Page
of 97
Search research articles
Search
Showing results (931-940 of 968) with videos related to
Sort By:
Page
of 97
Blood Advances
|
April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL Amyloidosis
Maximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Blood Cancer Journal
|
June 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma
Binoy Yohannan, Benjamin W Langworthy, Lindsey E Turner, et al.
Mayo Clinic Proceedings
|
April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013
Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Nature Genetics
|
August 20, 2025
Temporal genomic dynamics shape clinical trajectory in multiple myeloma
Francesco Maura, Marcella Kaddoura, Alexandra M Poos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Antonio Palumbo, Hervé Avet-Loiseau, Stefania Oliva, et al.
Blood
|
July 8, 2017
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma
Jonas Paludo, Joseph R Mikhael, Betsy R LaPlant, et al.
The New England Journal of Medicine
|
December 9, 2014
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma
A Keith Stewart, S Vincent Rajkumar, Meletios A Dimopoulos, et al.
American Journal of Hematology
|
January 11, 2021
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort
Maria Eleni Drosou, Lisa E Vaughan, Eli Muchtar, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2024
Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma
Francesco Maura, Marcella Kaddoura, Alexandra M Poos, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 10, 2001
The discovery of sulfonylated dipeptides as potent VLA-4 antagonists
W K Hagmann, P L Durette, T Lanza, et al.
Page
of 97